Balsm Alofoq Medical Company (TADAWUL:9620)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
71.75
-0.45 (-0.62%)
Jul 24, 2025, 3:10 PM AST

TADAWUL:9620 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
19.8618.0317.01
Revenue Growth (YoY)
10.11%6.04%-
Cost of Revenue
10.479.878.7
Gross Profit
9.388.178.31
Selling, General & Admin
4.694.154.68
Other Operating Expenses
---0.11
Operating Expenses
4.273.824.58
Operating Income
5.124.343.73
Interest Expense
-0.07-0.09-0.1
Pretax Income
5.044.263.63
Income Tax Expense
0.260.10.12
Net Income
4.784.163.51
Net Income to Common
4.784.163.51
Net Income Growth
14.85%18.47%-
Shares Outstanding (Basic)
11-
Shares Outstanding (Diluted)
11-
Shares Change (YoY)
38.36%--
EPS (Basic)
4.685.64-
EPS (Diluted)
4.685.64-
EPS Growth
-16.99%--
Free Cash Flow
5.27-1.744.53
Free Cash Flow Per Share
5.16-2.36-
Dividend Per Share
3.000--
Gross Margin
47.26%45.29%48.87%
Operating Margin
25.77%24.09%21.95%
Profit Margin
24.07%23.08%20.66%
Free Cash Flow Margin
26.55%-9.65%26.61%
EBITDA
6.055.174.63
EBITDA Margin
30.45%28.65%27.25%
D&A For EBITDA
0.930.820.9
EBIT
5.124.343.73
EBIT Margin
25.77%24.09%21.95%
Effective Tax Rate
5.24%2.27%3.32%
Advertising Expenses
0.430.360.17
Source: S&P Global Market Intelligence. Standard template. Financial Sources.